From the mid-1980s, numerous reports of invasive group A streptococcal infections suggested that "highly virulent clones" were responsible. However, there have been virtually no extensive reports and comparisons of diverse temporal and geographic community isolates from uncomplicated throat infections to confirm the hypothesis. A unique collection of such "control" strains allowed in-depth assessment of association of M serotypes 1, 3, and 28 "clones" with invasive infections. Clones were defined by using small-fragment chromosomal restriction-enzyme analysis, pulsed-field gel electrophoresis, and M protein gene (emm) sequencing. After comparison with controls, no clone within these M serotypes had statistically increased association with invasive infections. The prevalence of specific virulence-associated clones appeared to essentially reflect their normal population prevalence. Although this does exclude other potential streptococcal factors, these findings suggest that host factors including individual and population-based immunity must also be significant in influencing infection potential.
Although never completely relinquishing their ability to cause outbreaks of serious infections and life-threatening sequelae, by the middle of the twentieth century, group A streptococci (GAS) were almost as likely to be considered nuisance infections in most industrialized countries. Streptococcal infections were not uncommon but they relatively seldom proved to be serious [1, 2] . As a result, it was surprising in the mid-and late 1980s when significant outbreaks of both suppurative and nonsuppurative complications of group A streptococcal infections began to be reported worldwide [3] . There was no obvious explanation for these apparent epidemiologic changes. Attempts to explain the problem by clinicians, epidemiologists, and laboratory scientists continued as the problem persisted through the decade of the 1990s.
One logical approach was to attempt to document and define changes in the virulence of the responsible organisms, even though it became clear that multiple serotypes were involved [4] . Early reports suggested the possibility of specific disease-producing "clones" that caused this unexpected epidemiologic phenomenon. [5] [6] [7] [8] [9] [10] [11] [12] . However, none of the relatively few attempts contained appropriate comparisons with sufficiently large and diverse samples of prevalent group A streptococcal isolates circulating in multiple communities to definitively confirm a role for "highly virulent" strains. Researchers were left with the concern that there was not sufficient documentation, either epidemiologic or laboratory and molecular, and that there were, in fact, definable specific highly "virulent" clones present in the general population.
During the time of this apparent reemergence of group A streptococcal invasive infections, our laboratory continuously received numerous group A streptococcal isolates from persons with severe systemic infections from North America and from abroad. Of equal importance, however, we amassed a large collection of isolates from children and adults with only uncomplicated pharyngeal infections, because of our continuing interest in the epidemiology and management of uncomplicated group A streptococcal pharyngitis. These latter strains originated from most US states and were collected essentially during the entire period of the reemergence (1986) (1987) (1988) (1989) (1990) (1991) (1992) (1993) (1994) (1995) (1996) (1997) (1998) (1999) (2000) (2001) .
Our laboratory's isolate collections have provided a unique opportunity to address the issue of inherent virulence by enabling comparison of the similarities and differences of the strains isolated from patients with severe group A streptococcal infections with those associated with patients with only clinically uncomplicated pharyngitis (UP). In the present study, we compared isolates belonging to M serotypes 1, 3, and 28 by using several specific molecular techniques previously reported by other investigators as being able to identify virulent clones of GAS. These techniques included small-fragment chromosomal restriction-enzyme analy-sis (REA), pulsed-field gel electrophoresis (PFGE), M protein gene (emm) sequence analysis, and emm restriction fragment analysis.
Materials and Methods
Isolates. We studied group A streptococcal isolates sent to the World Health Organization Collaborating Center for Reference and Research on Streptococci at the University of Minnesota by clinicians, clinical microbiology laboratories, and basic science investigators in the United States during 1986-2001. These isolates were from patients with severe invasive streptococcal infections (ISI) and were examined in our laboratory only after direct confirmation of each patient's specific clinical diagnosis. Included in the category of ISI isolates were those associated with group A streptococcal toxic shock syndrome (TSS), necrotizing fasciitis (NF), and septicemia plus group A streptococcal infections of other normally sterile sites (e.g., cerebrospinal fluid, peritoneal fluid, bone, deep tissue abscess, myocardium, joint aspirate, and muscle). During the same time period, throat isolates of GAS were sent to our laboratory from across the United States for characterization only, as a part of multiple large multicenter studies of uncomplicated group A streptococcal pharyngitis or tonsillitis (i.e., UP). The UP isolates from patients in the general population have been defined as "population control strains." Our laboratory played no part in the clinical treatment of these patients.
The specific group A streptococcal isolates evaluated in this study represented a broad geographic and temporal distribution. To minimize sample bias, only 1 strain per patient, cluster, or outbreak was included in the studies and analyses reported here. The pharyngeal "control" isolates were selected to represent, as closely as possible, the same time periods as those of the ISI isolates. Although no specific attempt was made to geographically match the control strains with the ISI isolates, there proved to be considerable overlap in states of origin. The serotypes studied and their sources and dates of isolation are shown in table 1. The M serotype, internationally recognized, laboratory reference strains used as M protein-emm controls in these studies were as follows: M 1 strain T1/195/2 (University of Minnesota [U of MN] 71675; obtained from R. Lancefield, Rockefeller University, New York); M-3 strain 4/55 (U of MN 85335; obtained from J. Rotta, Institute of Hygiene, Prague); and M-28 strain T28/ 150A/4 (U of MN 71698; obtained from R. Lancefield). All molecular genetic studies of these clinical group A streptococcal isolates were performed without specific knowledge of their origins by the laboratory personnel performing the studies.
Serotyping. Group A streptococcal isolates were characterized by T-agglutination pattern and by M serotyping and/or opacity factor inhibition, by methods described elsewhere [13] [14] [15] [16] .
REA. Strains were grown in Todd-Hewitt broth with yeast extract and lysed by using mutanolysin and lysozyme. Chromosomal DNA was precipitated with ethanol and washed twice with phenol/ chloroform. The DNA was digested with Hae III (Fisher Scientific), and the restriction patterns were photographed after agarose gel electrophoresis and staining with ethidium bromide [5, 17] .
PFGE. PFGE was performed with a slight modification of methods described elsewhere [18] . Agarose plugs were prepared by using GAS grown overnight in Todd-Hewitt broth. The cells were lysed with lysozyme and mutanolysin, and the DNA was digested by using Sma I restriction enzyme (New England Biolabs). PFGE was performed with a CHEF DRII electrophoresis system (BioRad Laboratories). The resulting gels were stained with ethidium bromide, photographed, and analyzed by use of a Kodak Electrophoresis Documentation and Analysis System (Kodak Scientific Imaging Systems).
Analysis of emm. Within each M serotype, strains for emm studies were selected to represent each of the chromosomal REA patterns while also representing a broad geographic and temporal distribution. The homology of emm was evaluated in 2 ways. First, emm polymerase chain reaction (PCR) amplicons were digested with restriction enzymes and separated by gel electrophoresis, and the resulting emm enzyme restriction patterns were photographed and compared. Second, DNA emm sequence analysis was performed on strains representative of each emm restriction pattern and type of infection (ISI or UP). These emm sequences then were compared with each other and with published sequences for that M serotype [19, 20] .
The specific emm protocols were as follows: streptococcal strains were grown overnight at 37 C in Todd-Hewitt broth containing an additional 1% neopeptone (Difco), the cells were collected by centrifugation, the chromosomal DNA was extracted, and the emm gene was amplified by using procedures published elsewhere [21] . The emm gene of serotype M-28 was amplified by PCR, using primers 1 0 and 2, as described by Whatmore et al. [19] . M serotypes 1 and 3 were amplified by using a slightly truncated version of the "all M" primers of Podbielski et al. [22] . The forward primer sequence used was 5 0 -ATAAGGAGCATAAAAATGGCT-3 0 ; the reverse primer sequence was 5 0 -AGCTTAGTTTTCTTCTTTGCG-3 0 . The resulting emm gene amplicons were digested overnight at 37 C by use of Hinc II and Hae III restriction enzymes [23] , and the resulting restriction digests were analyzed after agarose gel electrophoresis and staining with ethidium bromide. The emm restriction patterns were photographed, and the individual band sizes were determined with a Kodak Electrophoresis Documentation and Analysis System 120.
For emm sequence analysis, the emm gene amplicons were purified by use of the Wizard PCR Preps DNA purification system (Promega), and the 5 0 hypervariable region of the gene was sequenced by using primer emmseq2 [21] . Automated DNA sequencing was done by using either an ABI Prism 377 DNA sequencer or an ABI310 genetic analyzer (Applied Biosystems), and sequence analysis was performed by using DNA sequencing analysis software (version 
Results

M-1 Serotype Studies
M-1 REA. Figure 1A shows the results of REA of 186 M serotype 1 isolates from patients with either UP (n ¼ 98) or invasive group A streptococcal infections (n ¼ 88). These M-1 isolates, originating from 39 different states and the District of Columbia over 15 years (1987-2001) , produced 9 different REA patterns (arbitrarily designated 1b-1j). Although 79 (90%) of the 88 iso- lates from patients with invasive group A streptococcal infections exhibited pattern 1c, this same pattern was also observed in 78 (80%) of 98 M-1 isolates from patients with only UP. This association of REA pattern 1c isolates with ISI approached but did not reach statistical significance (P ¼ :0689). Included in these analyses were 2 isolates also reported by Cleary et al. [5] , who identified them as M1 "invasive" and M1 "noninvasive." In the present study, these isolates exhibited REA patterns 1c and 1b, respectively. The reference M-1 strain (Lancefield T1/195/2; U of MN 71675) exhibited REA pattern 1a, a pattern not observed in other clinical isolates tested.
Of the M-1 isolates studied, 34 (39%) were identified by the submitting laboratory as being associated with TSS, and 14 (16%) were identified as being associated with NF. As was observed with the ISI isolates overall, the REA pattern distribution of these isolates appeared to simply mirror that in those isolates recovered from the general population; 88% and 86%, respectively, exhibited REA pattern 1c. Although the numbers are too small to draw definitive conclusions, we observed no statistically significant increased association of any M-1 REA pattern with either TSS or NF (data not shown).
M-1 emm restriction analysis. Restriction analysis of emm was performed on 88 (47%) of the 186 M-1 isolates by using a combination of Hae III and Hinc II restriction enzymes. These 88 isolates were selected to provide a representative sample, both geographically and temporally, of each of the previously described REA patterns. All 88 (and the M-1 reference strain) had the same emm restriction pattern, with 3 bands of 909, 510, and 127 bp (table 2) .
M-1 emm sequence analysis. Fifty-five (63%) of these 88 M-1 isolates, also selected for geographic and temporal diversity, had emm sequencing performed and compared over the first 400 bases (table 2) . The emm allele arbitrarily designated 1a was associated with 43 (78%) of the isolates and was about equally distributed between the invasive isolates and the control isolates. The 1a allele was 100% homologous with the emm sequence of the Lancefield M-1 reference strain T1/195/2 and with GenBank accession numbers X62131 and U20094, a 300-bp sequence described by Musser et al. [24] , who designated them as emm 1.0 [24] .
Six of the remaining 12 M-1 strains had a common emm sequence that was arbitrarily designated 1b. This emm 1b sequence is 100% homologous with GenBank accession number U20097, another 300-bp sequence described and designated by Musser et al. [24] as emm 1.3. The 6 remaining M-1 isolates had 5 unique emm sequences arbitrarily designated 1c-1g. The specific putative amino acid changes defining each of these emm 1 alleles are shown in table 3. The DNA sequences of emm alleles 1b through 1g have been submitted to GenBank and assigned accession numbers AY082016 through AY082021, respectively. Eighteen (33%) of the M-3 isolates received were identified by the submitting laboratory as being associated with TSS, and 9 (17%) were identified as being associated with NF. As with the M-3 ISI isolates overall, the REA pattern distribution of these ISI strains appeared to simply reflect that observed in the general population; 83% and 100%, respectively, exhibited REA pattern 3b. On the basis of this relatively small sample, we found no statistically significant increased association of any M-3 REA pattern with either TSS or NF (data not shown).
M-3 PFGE analysis. We also tested 87 of the 101 M-3 isolates by PFGE ( figure 1C) . Fourteen of the isolates originally tested by REA were not viable when PFGE testing was performed later. One of the nonviable isolates was an REA pattern 3a from a patient with ISI. The remaining 13 strains were all REA pattern 3b (9 from UP and 4 from ISI). By use of sma I restriction enzyme, 8 different PFGE patterns were observed among these 87 strains. The predominant M-3 PFGE pattern was arbitrarily designated 3B; it was observed in 30 (79%) of 38 UP isolates, compared with 34 (69%) of 49 ISI isolates (P ¼ :3399). Included in these studies were several strains previously reported to represent a highly virulent clone of M-3 [7, 8] . These strains, originally identified as PFGE-1 in those reports, exhibited PFGE pattern 3B in the present study, the PFGE pattern most often observed in strains recovered nationwide from patients with UP.
M-3 emm restriction analysis. Eighty-four (83%) of the 101 M-3 isolates had emm restriction digests evaluated, and 2 patterns, differing only in the size of 1 band, were observed (table 4) . Restriction patterns of 83 (99%) of the isolates (plus the M-3 reference strain) had 4 bands of 1300, 330, 170, and 90 bp; this pattern was arbitrarily designated 3A. A single isolate, associated with an invasive infection, had a nearly identical emm restriction pattern but with a slightly smaller large band (1170 vs. 1300 bp). This pattern was arbitrarily designated pattern 3G.
M-3 emm sequence analysis. Forty-four (52%) of the 84 M-3 clinical isolates previously analyzed by emm restriction analysis had the emm gene sequenced and compared over the first 400 bases (table 4). Overall, 8 slightly different emm sequences were observed and arbitrarily designated emm 3b-3i. Thirty-five (80%) of the isolates, including 1 with the discordant emm restriction pattern, had identical emm sequences over 400 bases (designated sequence 3b). This emm 3b allele was associated with 21 (88%) of 24 ISI isolates and 14 (70%) of 20 UP isolates. This difference was not statistically significant (P ¼ :2607). None of the remaining 7 emm 3 alleles identified was associated with . 5% of the M-3 isolates studied. The specific amino acid changes defining these different emm 3 alleles are detailed in figure 1D ). REA pattern 28d was the most common (45% of all Total  101  84  -35  2  1  2  1  1  1  1 NOTE. The M-3 reference strain had emm restriction pattern 3A and emm allele 3a. ERP, emm gene enzyme restriction pattern; REA, restriction-enzyme analysis.
M-28 isolates), but again, there was no significantly increased association of this pattern with ISI (P ¼ 1:000). The reference M-28 strain (Lancefield strain T28/150A/4; U of MN 71698) exhibited REA pattern 28a, again a pattern not observed in the clinical isolates tested.
M-28 emm restriction analysis. Of the 37 M-28 strains selected to represent each of the M-28 REA patterns, as well as geographic and temporal diversity, 34 (92%) had emm restriction patterns evaluated. Two different patterns were observed and were seen in nearly equal numbers (table 6). Pattern 28A consisted of 3 bands of 460, 210, and 190 bp. Pattern 28B was identical to 28A, except for an additional band of 110 bp. The M-28 reference strain had emm restriction pattern 28A. There was no significant association of emm restriction pattern with severity of infection.
M-28 emm sequence analysis. Nineteen of the M-28 strains selected to represent each emm restriction pattern were also sequenced. All had identical emm sequences over the first 400 bases. The sequences all shared 100% homology with the emm sequence of Lancefield reference M-28 strain T28/150A/4 and with the 260-bp sequence of GenBank accession number U11948.
Discussion
Beginning in the mid-1980s, reports of severe invasive group A streptococcal infections increased dramatically. At the same time, a significant increase in the incidence of rheumatic fever was noted in several US regions [3, [25] [26] [27] [28] [29] . This reemergence of serious group A streptococcal infections provided renewed impetus for both basic scientists and epidemiologists to attempt to define factors responsible for a seeming "virulence enhancement" of the group A streptococcus and for subsequent disease manifestations and clinical outcomes.
A number of studies examined streptococci isolated from severe invasive infections and, by using phenotypic or molecular classification methods, attempted to define specific virulent or invasive clones [5, 8, [30] [31] [32] [33] . Although these studies provided valuable information, many lacked either adequate geographic and temporal diversity or, more importantly, adequate numbers of homologous serotype population control strains isolated from healthy subjects with only UP. Studies of isolates with limited geographic and temporal diversity might bias interpretation of results toward clonal relatedness, and studies without appropriate control strains cannot definitively assess the biologic significance and possible causative pathogenic role of seemingly virulent clones.
In 1992, we described the distribution of specific group A streptococcal M protein serotypes among strains isolated during 1988-1990 from patients with severe systemic infections from all regions of the United States and compared this distribution with that of concomitantly isolated community control isolates. [4] . That study indicated that M serotypes 1 and 3 were significantly more frequently associated with invasive group A systemic infections than with uncomplicated pharyngeal infections [4] . Other serotypes, such as M-2, -4, -12, and -28, were significantly underrepresented among invasive isolates. Those findings suggested that streptococci of certain M protein serotypes might possess properties that enhance their potential for virulence. However, these published data also raised the important question of whether this virulence potential was associated with specific strains within a serotype [4] .
Also in 1992, Single and Martin [34] and Cleary et al. [5] demonstrated that DNA restriction analysis could be used to identify clonal differences within distinct M serotypes. Such reports prompted us to extend our previous observations and to attempt to determine whether this apparent increased virulence potential might be due to specific virulent clones within these M serotypes. By comparing representative isolates from patients with invasive group A streptococcal infections and isolates from our large streptococcal collection of population controls, our premise was that, if a clone truly has properties that enhance its virulence, then that clone should be overrepresented in isolates from patients with serious infections.
A preliminary report of our findings, which employed REA to define group A streptococcal clones, was presented in 1996 [35] . The present report expands those findings and also attempts 3  4  5  23  24  25  30  31  32  37  38  39  40  41  42  68  69  70  73  74  75 3a NOTE. M protein gene (emm) allele 3a has complete homology with GenBank accession no. X80168 (residues 42-151 of the deduced mature protein); allele 3b has complete homology with accession no. U40231 (residues 42-151 of the deduced mature protein). The emm allele 3d has complete homology with emm allele 3.4 in the Centers for Disease Control and Prevention emm sequence database. The emm 3c and 3e-3i DNA sequences have been submitted to GenBank and assigned accession numbers AY082022-AY082027, respectively. (1 June) to corroborate other published reports that attempted to identify virulent streptococcal clones by using the same molecular techniques described in those reports. In addition to REA, we also used emm sequencing and PFGE.
DNA Analyses of Group
Our observation that strains of M serotypes 1, 3, and 28 were composed of multiple clones (on the basis of REA) is not unexpected. However, the finding that no single clone within these serotypes demonstrated any statistically significant increased association with invasive infections was not anticipated. For example, several reports refer to a highly virulent clone of M-3 streptococci causing invasive disease in Minnesota and elsewhere in the world [6] [7] [8] . Our examination of a larger and more diverse sample of M-3 isolates, including a separate examination of the same isolates used to define the invasive clone described in those reports, revealed that the DNA restriction pattern of the invasive strain (REA pattern 3b/PFGE pattern 3B) was identical to most of the M-3 isolates associated with uncomplicated pharyngeal infections in multiple US geographic regions during the 10-year period 1986-1995. In the present study, we found no evidence that these M-3 clones (previously referred to as "highly virulent" [7] ) had any significantly increased propensity for association with invasive infections, compared with M-3 clones prevalent in the general population.
Although the number of strains of M serotype 28 available for the present study might be considered to be relatively small, it again appears that the association of individual clones of this serotype with invasive group A streptococcal infection simply paralleled the distribution of those clones causing only UP in the general population. No M-1 clone showed any statistically significant association with invasive infections, but strains exhibiting REA pattern 1c approached significance (P ¼ :0689). However, this association was not as great as that observed by Cleary et al. [5] in their initial description of this clone (P ¼ :0035). The difference in the 2 reports might possibly be explained by the larger number and greater geographic diversity of the isolates included in the present report, by the slightly different time periods evaluated in the 2 studies or, perhaps, by differences in strain selection criteria.
We were particularly interested in the possibility that specific alleles of emm genes might be associated with enhanced virulence. For example, in one M-3 outbreak of invasive infections, a specific emm allele, designated emm 3.4, was associated with a majority of the infections [8] . However, when we sequenced emm 3 genes from invasive infections and from UP from multiple geographic sources, we found that emm 3.4 allele (our emm sequence 3b) was the most prevalent emm 3 allele nationwide during the 10-year period in both invasive and uncomplicated group A streptococcal infections. Thus, in contrast to the previous report, we found no evidence that strains with the emm 3.4 allele were disproportionately associated with more severe infections.
Similarly, our findings with M serotypes 1 and 28 revealed that no specific emm allele was significantly associated with invasive infection. However, our study of M-1 strains revealed that REA pattern 1c isolates had emm sequences with > 1 nonsynonymous single-base substitutions relative to REA 1b isolates (tables 2 and 3). This allelic variation would be predicted to alter the amino terminal hypervariable region of the mature M protein, the region containing epitopes important in opsonization by type-specific antibodies [36] [37] [38] [39] [40] . Although admittedly speculative, it is possible that the emm allelic variation exhibited by the REA 1c isolates might have offered these strains an advantage in withstanding the pressures of herd immunity. Compatible with that theory are reports by de Malmanche and Martin [38] , Villaseñor-Sierra et al. [39] , and Eriksson et al. [41] , suggesting that opsonization of M-1 streptococci by human serum may be strain specific. Amino acid variation within the M protein molecule was shown to be an important factor in this variable susceptibility to phagocytosis [39] .
Also consistent with a relative decrease in herd immunity is the observation by Cleary et al. [5] that the prevalence of M-1 invasive isolates (REA 1c) increased significantly and noninva- NOTE. The Lancefield M-28 reference strain T28/150A/4 had emm restriction pattern 28A and emm allele 28a. ERP, emm gene enzyme restriction pattern; REA, restriction-enzyme analysis.
a The emm gene of this isolate could not be amplified with either of the primer sets used in this study.
sive isolates (REA 1b) decreased from the early to the late 1980s. Furthermore, Schwartz et al. [2] observed that, from 1972 to 1988, isolates of M serotype 1 (and M-3) significantly increased as a percentage of GAS received for analysis by the CDC in Atlanta [2] . That report also revealed that, by the late 1980s, M-1 and M-3 were the most common serotypes encountered. Several reports from our laboratory further indicated that this preponderance of M-1 and M-3 strains in the general population continued into the mid-1990s [4, 42, 43] .
Based on these facts, it is logical that the observed reemergence of invasive infections associated with M serotypes 1 and 3 GAS during the late 1980s and 1990s was at least partially, and perhaps primarily, a result of the increased numbers of strains of these serotypes circulating in the general population at that time. Kiska et al. [32] cite several studies suggesting a correlation between an increase in noninvasive infections and the temporally associated appearance of invasive streptococcal infections. Therefore, unless appropriate controls are included, the observation that a specific clone is associated with a relatively high percentage of invasive infections during an outbreak might easily lead to an incorrect conclusion that a specific clone has increased virulence properties. Our data strongly suggest that such a microbiologic equivalent of "guilt by association" can easily be misleading; the high percentages associated with ISI may simply reflect a high prevalence of that organism in the general population (as shown in figure 1) .
The argument has been made that specific virulent clones of GAS are widely distributed in the population, and the population, especially symptomatic and asymptomatic school children, serves as the reservoir for severe infections [8, 32, 44] . On that basis, some have proposed that prospective surveillance of throat cultures for virulent clones of GAS be carried out in order to "alert medical care personnel about the potential for invasive GAS disease in a region or community" [6] . On the basis of our results presented here and of findings in other published reports, we believe that this may be impractical. Many clones have been associated with invasive infections [30-33, 45, 46] , and isolation of clones not previously reported to be associated with virulence might give false impression that such strains are benign. Furthermore, our findings suggest that clones previously identified as virulent are, in fact, indistinguishable from prevalent strains that cause uncomplicated pharyngeal infections in the general population.
When attempting to evaluate bacterial factors and their role in determining the clinical progress of human group A streptococcal infection, it is equally crucial to consider human host defense mechanisms, especially the potential role of antibody to M protein or to other virulence factors. As hypothesized by Stevens [27] , the presence of antibodies to the M protein of an invading organism would probably prevent colonization and subsequent severe infection. In a host without M serotype-specific antibody, colonization would be more likely to occur, and if this progressed to bacteremia, the course of infection might be determined, for example, by the host levels of antibody to streptococcal pyrogenic exotoxin A [27] . It is highly probable that the vast majority of patients who develop invasive infections or rheumatic fever are infected by contact with otherwise healthy persons (most likely children) with relatively benign infections. Although direct transmission of invasive streptococcal infections has been reported and represents an increased risk, this appears to be relatively rare [47, 48] . Host susceptibility is undoubtedly a major factor in determining whether colonization with a normally benign Streptococcus organism may induce a life-threatening invasive infection.
In accordance with our previous studies, we still favor the hypothesis that group A streptococcal strains of M serotypes 1 and 3 have an increased association with invasive infections [4] . However, the findings presented in this report do not preclude the possibility that some other specific streptococcal factor(s) (known or unknown) play a crucial role in group A streptococcal virulence and capacity for invasion. Methods classically used to identify clones may simply lack sufficient resolution to detect such factors. Further studies that use precise molecular methods but always including appropriate normal population control strains will be essential to resolve this issue.
Our data provide little direct support for the hypothesis that a recent emergence of highly virulent clones of GAS is the primary explanation for the recent invasive infections. Although there is some evidence [5] that a new clone of M-1 streptococci became predominant during the time of the emergence of these invasive infections, there is insufficient historical, epidemiological, and clinical data to definitively assess the comparative virulence potential of contemporary and antecedent M-1 clones. Stevens [49] suggested that, if there had been a sudden reemergence of such a clone(s), one would expect large epidemics of invasive infections with high attack rates. This has not been observed or reported. Thus, the observations and reports likely are due to a complex interplay between as yet incompletely identified bacterial virulence factors, bacterial gene regulation, and host factors, including individual and population-associated immunity. Unraveling this complex web of factors will be crucial to development of effective strategies for prevention of these devastating invasive infections. We believe that the detailed analyses presented in this report of 3 distinct serotypes (M-1, M-3, and M-28) strongly support the importance of the use of appropriate control strains in future studies to enhance understanding of invasive group A streptococcal infections.
